CD24 and melanoma: In melanoma, LKB1 loss display that it may promote melanoma invasion by disrupting directional migration toward extracellular matrix or by inducing the SRC family kinase (SFK)-dependent expansion of a CD24+ tumor subpopulation [14–16].